| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michael R Littner, Clete Kushida, W McDowell Anderson, Dennis Bailey, Richard B Berry, Max Hirshkowitz, Sheldon Kapen, Milton Kramer, Teofilo Lee-Chiong, Kasey K Li, Daniel L Loube, Timothy Morgenthaler, Merrill Wis. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. vol 27. issue 3. 2004-08-11. PMID:15164914. |
practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. |
2004-08-11 |
2023-08-12 |
Not clear |
| Michael R Littner, Clete Kushida, W McDowell Anderson, Dennis Bailey, Richard B Berry, Max Hirshkowitz, Sheldon Kapen, Milton Kramer, Teofilo Lee-Chiong, Kasey K Li, Daniel L Loube, Timothy Morgenthaler, Merrill Wis. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. vol 27. issue 3. 2004-08-11. PMID:15164914. |
dopaminergic agents, particularly dopamine agonists, have been used with increasing frequency in the treatment of restless legs syndrome and periodic limb movement disorder. |
2004-08-11 |
2023-08-12 |
Not clear |
| Michael R Littner, Clete Kushida, W McDowell Anderson, Dennis Bailey, Richard B Berry, Max Hirshkowitz, Sheldon Kapen, Milton Kramer, Teofilo Lee-Chiong, Kasey K Li, Daniel L Loube, Timothy Morgenthaler, Merrill Wis. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. vol 27. issue 3. 2004-08-11. PMID:15164914. |
recommendations are based on the accompanying comprehensive review of the medical literature regarding the dopaminergic treatment of restless legs syndrome (rls) and periodic limb movement disorder (plmd), which was developed by a task force commissioned by the american academy of sleep medicine. |
2004-08-11 |
2023-08-12 |
Not clear |
| Wayne A Hening, Richard P Allen, Christopher J Earley, Daniel L Picchietti, Michael H Silbe. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. vol 27. issue 3. 2004-08-11. PMID:15164915. |
an update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. |
2004-08-11 |
2023-08-12 |
Not clear |
| Wayne A Hening, Richard P Allen, Christopher J Earley, Daniel L Picchietti, Michael H Silbe. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. vol 27. issue 3. 2004-08-11. PMID:15164915. |
this paper reviews evidence from april, 1998 through april 2002 for the dopaminergic treatment of the restless legs syndrome (rls) and periodic limb movement disorder (plmd). |
2004-08-11 |
2023-08-12 |
Not clear |
| Wayne A Hening, Richard P Allen, Christopher J Earley, Daniel L Picchietti, Michael H Silbe. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. vol 27. issue 3. 2004-08-11. PMID:15164915. |
for this reason, the restless legs syndrome task force and the standards of practice committee decided to update the evidence on dopaminergic treatment of these conditions. |
2004-08-11 |
2023-08-12 |
Not clear |
| Karin Stiasny-Kolster, J Carsten Möller, Johannes Zschocke, Oliver Bandmann, Werner Cassel, Wolfgang H Oertel, Georg F Hoffman. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Movement disorders : official journal of the Movement Disorder Society. vol 19. issue 2. 2004-08-02. PMID:14978675. |
normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. |
2004-08-02 |
2023-08-12 |
human |
| Karin Stiasny-Kolster, Wolfgang H Oerte. Low-dose pramipexole in the management of restless legs syndrome. An open label trial. Neuropsychobiology. vol 50. issue 1. 2004-07-13. PMID:15179023. |
dopaminergic agents are considered the treatment of choice for restless legs syndrome (rls); levodopa is the only substance licensed for this disorder in some european countries. |
2004-07-13 |
2023-08-12 |
Not clear |
| John W Winkelman, Lindsay Johnsto. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep medicine. vol 5. issue 1. 2004-05-20. PMID:14725821. |
dopaminergic agents have become first-line treatments for restless legs syndrome (rls). |
2004-05-20 |
2023-08-12 |
Not clear |
| E K Tan, S C Ho, P Eng, L M Loh, L Koh, S Y Lum, M L Teoh, Y Yih, D Kho. Restless legs symptoms in thyroid disorders. Parkinsonism & related disorders. vol 10. issue 3. 2004-04-27. PMID:15036169. |
dopaminergic dysfunction is associated with thyroid disorders and restless legs syndrome (rls). |
2004-04-27 |
2023-08-12 |
Not clear |
| Joan Santamaria, Alex Iranzo, Eduard Tolos. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep medicine. vol 4. issue 2. 2004-01-05. PMID:14592347. |
development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. |
2004-01-05 |
2023-08-12 |
Not clear |
| Jing Li, Lan-Dian Hu, Wei-Jun Wang, Yu-Guang Chen, Xiang-Yin Kon. Linkage analysis of the candidate genes of familial restless legs syndrome. Yi chuan xue bao = Acta genetica Sinica. vol 30. issue 4. 2003-12-12. PMID:12812056. |
this research was performed to investigate the relationship between 16 candidate genes responsible for dopaminergic transmission or iron metabolism and familial restless legs syndrome. |
2003-12-12 |
2023-08-12 |
Not clear |
| Jing Li, Lan-Dian Hu, Wei-Jun Wang, Yu-Guang Chen, Xiang-Yin Kon. Linkage analysis of the candidate genes of familial restless legs syndrome. Yi chuan xue bao = Acta genetica Sinica. vol 30. issue 4. 2003-12-12. PMID:12812056. |
familial restless legs syndrome may be caused by another gene related to dopaminergic transmission and iron metabolism or there is new mechanism involved in this disease. |
2003-12-12 |
2023-08-12 |
Not clear |
| D Garcia-Borreguero, O Larrosa, Y de la Llav. Circadian aspects in the pathophysiology of the restless legs syndrome. Sleep medicine. vol 3 Suppl. 2003-12-09. PMID:14592162. |
several pieces of evidence suggest that a dopaminergic dysfunction might play a key role in the pathophysiology of restless legs syndrome (rls), including the therapeutic effects of dopaminergic drugs and the results of several positron emission tomography and single photon emission computed tomography studies. |
2003-12-09 |
2023-08-12 |
Not clear |
| L S Appiah-Kubi, S Pal, K Ray Chaudhur. Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS. Sleep medicine. vol 3 Suppl. 2003-12-09. PMID:14592168. |
restless legs syndrome (rls), parkinson's disease, and sustained dopaminergic therapy for rls. |
2003-12-09 |
2023-08-12 |
Not clear |
| Svenja Happe, Cornelia Sauter, Gerhard Klösch, Bernd Saletu, Josef Zeitlhofe. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology. vol 48. issue 2. 2003-11-10. PMID:14504416. |
dopaminergic agents such as ropinirole are the drugs of first choice in treating restless legs syndrome (rls). |
2003-11-10 |
2023-08-12 |
Not clear |
| Cynthia L Comell. Restless legs syndrome: treatment with dopaminergic agents. Neurology. vol 58. issue 4 Suppl 1. 2003-09-15. PMID:11909990. |
restless legs syndrome: treatment with dopaminergic agents. |
2003-09-15 |
2023-08-12 |
Not clear |
| T C Wette. Restless legs syndrome: a review for the renal care professionals. EDTNA/ERCA journal (English ed.). vol 27. issue 1. 2003-03-13. PMID:12603074. |
in secondary restless legs syndrome the underlying illness should be treated first, but dopaminergic drugs may also be helpful. |
2003-03-13 |
2023-08-12 |
Not clear |
| Thomas C Wetter, Victor Collado-Seidel, Heide Oertel, Manfred Uhr, Alexander Yassouridis, Claudia Trenkwalde. Endocrine rhythms in patients with restless legs syndrome. Journal of neurology. vol 249. issue 2. 2002-10-16. PMID:11985379. |
there is increased evidence that the dopaminergic system plays a major role in the pathophysiology of the restless legs syndrome (rls). |
2002-10-16 |
2023-08-12 |
human |
| Martin Michaud, Jean-Paul Soucy, Allal Chabli, Gilles Lavigne, Jacques Montplaisi. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. Journal of neurology. vol 249. issue 2. 2002-10-16. PMID:11985381. |
spect imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. |
2002-10-16 |
2023-08-12 |
human |